Targeting BMP9-promoted human osteosarcoma growth by inactivation of notch signaling

Current Cancer Drug Targets

Volumn 14, Issue 3, 2014, Pages 274-285

  Li, Ruidong ^a,b   Zhang, Wenwen ^a,b,c   Cui, Jing ^a,b   Shui, Wei ^a,b   Yin, Liangjun ^a,b   Wang, Yang ^a   Zhang, Hongyu ^a,b   Wang, Ning ^b,d   Wu, Ningning ^a,b   Nan, Guoxin ^a,b   Chen, Xian ^a,b   Wen, Sheng ^a,b   Deng, Fang ^b,d   Zhang, Hongmei ^a,b   Zhou, Guolin ^b   Liao, Zhan ^b,e   Zhang, Junhui ^a,b   Zhang, Qian ^a,b   Yan, Zhengjian ^a,b   Liu, Wei ^a,b   Zhang, Zhonglin ^b   Ye, Jixing ^b   Deng, Youlin ^a,b   Luu, Hue H ^b   Haydon, Rex C ^b   He, Tong Chuan ^a,b   Deng, Zhong Liang ^a   more..

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^c Department of Laboratory Medicine Affiliated Hospital of Bingzhou Medical University   (China)

^d THIRD MILITARY MEDICAL UNIVERSITY   (China)

^e CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

BMP9; Bone tumorigenesis; Notch signaling; Osteogenesis; Osteosarcoma; Soft tissue tumors

Indexed keywords

BONE MORPHOGENETIC PROTEIN 9; DLL1 PROTEIN; JAGGED1; NOTCH RECEPTOR; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; NOTCH3 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; BONE DEVELOPMENT; CANCER GROWTH; CELL CYCLE PROGRESSION; CELL MIGRATION; CELL MIGRATION ASSAY; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; METASTASIS; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSTEOSARCOMA; PROTEIN EXPRESSION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR INVASION; TUMOR XENOGRAFT; UPREGULATION; CELL DIVISION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

CELL DIVISION; CELL LINE, TUMOR; GROWTH DIFFERENTIATION FACTOR 2; HUMANS; OSTEOSARCOMA;

EID: 84903725662     PISSN: 15680096     EISSN: 18735576     Source Type: Journal    
DOI: 10.2174/1568009614666140305105805     Document Type: Article

References (56)

1. Tang, N.; Song, W. X.; Luo, J.; Haydon, R. C.; He, T. C. Osteosarcoma development and stem cell differentiation. Clin. Orthop. Relat. Res. 2008, 466 (9), 2114-2130.
2. Marina, N.; Gebhardt, M.; Teot, L.; Gorlick, R. Biology and therapeutic advances for pediatric osteosarcoma. Oncologist 2004, 9 (4), 422-441.
3. Gorlick, R.; Anderson, P.; Andrulis, I.; Arndt, C.; Beardsley, G. P.; Bernstein, M.; Bridge, J.; Cheung, N. K.; Dome, J. S.; Ebb, D.; Gardner, T.; Gebhardt, M.; Grier, H.; Hansen, M.; Healey, J.; Helman, L.; Hock, J.; Houghton, J.; Houghton, P.; Huvos, A.; Khanna, C.; Kieran, M.; Kleinerman, E.; Ladanyi, M.; Lau, C.; Malkin, D.; Marina, N.; Meltzer, P.; Meyers, P.; Schofield, D.; Schwartz, C.; Smith, M. A.; Toretsky, J.; Tsokos, M.; Wexler, L.; Wigginton, J.; Withrow, S.; Schoenfeldt, M.; Anderson, B. Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary. Clin. Cancer Res. 2003, 9 (15), 5442-5453.
4. Meyers, P. A.; Gorlick, R. Osteosarcoma. Pediatr. Clin. North Am. 1997, 44 (4), 973-989.
5. Sandberg, A. A.; Bridge, J. A. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors. Cancer Genet. Cytogenet. 2003, 145 (1), 1-30.
6. Haydon, R. C.; Luu, H. H.; He, T. C. Osteosarcoma and osteoblastic differentiation: a new perspective on oncogenesis. Clin. Orthop. Relat. Res. 2007, 454, 237-246.
7. Wagner, E. R.; Luther, G.; Zhu, G.; Luo, Q.; Shi, Q.; Kim, S. H.; Gao, J. L.; Huang, E.; Gao, Y.; Yang, K.; Wang, L.; Teven, C.; Luo, X.; Liu, X.; Li, M.; Hu, N.; Su, Y.; Bi, Y.; He, B. C.; Tang, N.; Luo, J.; Chen, L.; Zuo, G.; Rames, R.; Haydon, R. C.; Luu, H. H.; He, T. C. Defective osteogenic differentiation in the development of osteosarcoma. Sarcoma 2011, 2011, 325238.
8. Luo, X.; Chen, J.; Song, W. X.; Tang, N.; Luo, J.; Deng, Z. L.; Sharff, K. A.; He, G.; Bi, Y.; He, B. C.; Bennett, E.; Huang, J.; Kang, Q.; Jiang, W.; Su, Y.; Zhu, G. H.; Yin, H.; He, Y.; Wang, Y.; Souris, J. S.; Chen, L.; Zuo, G. W.; Montag, A. G.; Reid, R. R.; Haydon, R. C.; Luu, H. H.; He, T. C. Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects. Lab Invest. 2008, 88 (12), 1264-1277.
9. Luu, H. H.; Song, W. X.; Luo, X.; Manning, D.; Luo, J.; Deng, Z. L.; Sharff, K. A.; Montag, A. G.; Haydon, R. C.; He, T. C. Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J. Orthop. Res. 2007, 25 (5), 665-677.
10. Deng, Z. L.; Sharff, K. A.; Tang, N.; Song, W. X.; Luo, J.; Luo, X.; Chen, J.; Bennett, E.; Reid, R.; Manning, D.; Xue, A.; Montag, A. G.; Luu, H. H.; Haydon, R. C.; He, T. C. Regulation of osteogenic differentiation during skeletal development. Front. Biosci. 2008, 13, 2001-2021.
11. Cheng, H.; Jiang, W.; Phillips, F. M.; Haydon, R. C.; Peng, Y.; Zhou, L.; Luu, H. H.; An, N.; Breyer, B.; Vanichakarn, P.; Szatkowski, J. P.; Park, J. Y.; He, T. C. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg. Am. 2003, 85-A (8), 1544-1552.
12. Kang, Q.; Sun, M. H.; Cheng, H.; Peng, Y.; Montag, A. G.; Deyrup, A. T.; Jiang, W.; Luu, H. H.; Luo, J.; Szatkowski, J. P.; Vanichakarn, P.; Park, J. Y.; Li, Y.; Haydon, R. C.; He, T. C. Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther. 2004, 11 (17), 1312-1320.
13. Luther, G.; Wagner, E. R.; Zhu, G.; Kang, Q.; Luo, Q.; Lamplot, J.; Bi, Y.; Luo, X.; Luo, J.; Teven, C.; Shi, Q.; Kim, S. H.; Gao, J. L.; Huang, E.; Yang, K.; Rames, R.; Liu, X.; Li, M.; Hu, N.; Liu, H.; Su, Y.; Chen, L.; He, B. C.; Zuo, G. W.; Deng, Z. L.; Reid, R. R.; Luu, H. H.; Haydon, R. C.; He, T. C. BMP-9 induced osteogenic differentiation of mesenchymal stem cells: Molecular mechanism and therapeutic potential. Curr. Gene Ther. 2011, 11 (3), 229-240.
14. Lamplot, J. D.; Qin, J.; Nan, G.; Wang, J.; Liu, X.; Yin, L.; Tomal, J.; Li, R.; Shui, W.; Zhang, H.; Kim, S. H.; Zhang, W.; Zhang, J.; Kong, Y.; Denduluri, S.; Rogers, M. R.; Pratt, A.; Haydon, R. C.; Luu, H. H.; Angeles, J.; Shi, L. L.; He, T. C. BMP9 signaling in stem cell differentiation and osteogenesis. Am. J. Stem Cell 2013, 2 (1), 1-21.
15. Sharff, K. A.; Song, W. X.; Luo, X.; Tang, N.; Luo, J.; Chen, J.; Bi, Y.; He, B. C.; Huang, J.; Li, X.; Jiang, W.; Zhu, G. H.; Su, Y.; He, Y.; Shen, J.; Wang, Y.; Chen, L.; Zuo, G. W.; Liu, B.; Pan, X.; Reid, R. R.; Luu, H. H.; Haydon, R. C.; He, T. C. Hey1 basic helixloop- helix protein plays an important role in mediating BMP9- induced osteogenic differentiation of mesenchymal progenitor cells. J. Biol. Chem. 2009, 284 (1), 649-659.
16. Guruharsha, K. G.; Kankel, M. W.; Artavanis-Tsakonas, S. The Notch signaling system: recent insights into the complexity of a conserved pathway. Nat. Rev. Genet. 2012, 13 (9), 654-666.
17. Penton, A. L.; Leonard, L. D.; Spinner, N. B. Notch signaling in human development and disease. Semin. Cell Dev. Biol. 2012, 23 (4), 450-457.
18. Engin, F.; Bertin, T.; Ma, O.; Jiang, M. M.; Wang, L.; Sutton, R. E.; Donehower, L. A.; Lee, B. Notch signaling contributes to the pathogenesis of human osteosarcomas. Human Mol. Genet. 2009, 18 (8), 1464-1470.
19. Kawakami, T.; Siar, C. H.; Ng, K. H.; Shimizu, T.; Okafuji, N.; Kurihara, S.; Hasegawa, H.; Tsujigiwa, H.; Nagatsuka, H.; Nagai, N. Expression of Notch in a case of osteosarcoma of the maxilla. Eur. J. Med. Res. 2004, 9 (11), 533-535.
20. Schnabel, M.; Fichtel, I.; Gotzen, L.; Schlegel, J. Differential expression of Notch genes in human osteoblastic cells. Intl. J. Mol. Med. 2002, 9 (3), 229-232.
21. Tanaka, M.; Setoguchi, T.; Hirotsu, M.; Gao, H.; Sasaki, H.; Matsunoshita, Y.; Komiya, S. Inhibition of Notch pathway prevents osteosarcoma growth by cell cycle regulation. Br. J. Cancer 2009, 100 (12), 1957-1965.
22. Zhang, P.; Yang, Y.; Nolo, R.; Zweidler-McKay, P. A.; Hughes, D. P. Regulation of NOTCH signaling by reciprocal inhibition of HES1 and Deltex 1 and its role in osteosarcoma invasiveness. Oncogene 2010, 29 (20), 2916-2926.
23. Zhang, P.; Yang, Y.; Zweidler-McKay, P. A.; Hughes, D. P. Critical role of notch signaling in osteosarcoma invasion and metastasis. Clin. Cancer Res. 2008, 14 (10), 2962-2969.
24. Su, Y.; Luo, X.; He, B. C.; Wang, Y.; Chen, L.; Zuo, G. W.; Liu, B.; Bi, Y.; Huang, J.; Zhu, G. H.; He, Y.; Kang, Q.; Luo, J.; Shen, J.; Chen, J.; Jin, X.; Haydon, R. C.; He, T. C.; Luu, H. H. Establishment and characterization of a new highly metastatic human osteosarcoma cell line. Clin. Exp. Metastasis 2009, 26 (7), 599-610.
25. Tang, N.; Song, W. X.; Luo, J.; Luo, X.; Chen, J.; Sharff, K. A.; Bi, Y.; He, B. C.; Huang, J. Y.; Zhu, G. H.; Su, Y. X.; Jiang, W.; Tang, M.; He, Y.; Wang, Y.; Chen, L.; Zuo, G. W.; Shen, J.; Pan, X.; Reid, R. R.; Luu, H. H.; Haydon, R. C.; He, T. C. BMP9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/beta-catenin signaling. J. Cell Mol. Med. 2009, 13 (8B), 2448-2464.
26. Kong, Y.; Zhang, H.; Chen, X.; Zhang, W.; Zhao, C.; Wang, N.; Wu, N.; He, Y.; Nan, G.; Zhang, H.; Wen, S.; Deng, F.; Liao, Z.; Wu, D.; Zhang, J.; Qin, X.; Haydon, R. C.; Luu, H. H.; He, T. C.; Zhou, L. Destabilization of heterologous proteins mediated by the GSK3beta phosphorylation domain of the beta-catenin protein. Cell Physiol. Biochem. 2013, 32 (5), 1187-1199.
27. Zhang, J.; Weng, Y.; Liu, X.; Wang, J.; Zhang, W.; Kim, S. H.; Zhang, H.; Li, R.; Kong, Y.; Chen, X.; Shui, W.; Wang, N.; Zhao, C.; Wu, N.; He, Y.; Nan, G.; Chen, X.; Wen, S.; Zhang, H.; Deng, F.; Wan, L.; Luu, H. H.; Haydon, R. C.; Shi, L. L.; He, T. C.; Shi, Q. Endoplasmic reticulum (ER) stress inducible factor cysteine-rich with EGF-like domains 2 (Creld2) is an important mediator of BMP9-regulated osteogenic differentiation of mesenchymal stem cells. PloS One 2013, 8 (9), e73086.
28. Zhang, W.; Zhang, H.; Wang, N.; Zhao, C.; Zhang, H.; Deng, F.; Wu, N.; He, Y.; Chen, X.; Zhang, J.; Wen, S.; Liao, Z.; Zhang, Q.; Zhang, Z.; Liu, W.; Yan, Z.; Luu, H. H.; Haydon, R. C.; Zhou, L.; He, T. C. Modulation of beta-catenin signaling by the inhibitors of MAP kinase, tyrosine kinase, and PI3-kinase pathways. Intl. J. Med. Sci. 2013, 10 (13), 1888-1898.
29. Chen, X.; Luther, G.; Zhang, W.; Nan, G.; Wagner, E. R.; Liao, Z.; Wu, N.; Zhang, H.; Wang, N.; Wen, S.; He, Y.; Deng, F.; Zhang, J.; Wu, D.; Zhang, B.; Haydon, R. C.; Zhou, L.; Luu, H. H.; He, T. C. The E-F hand calcium-binding protein S100A4 regulates the proliferation, survival and differentiation potential of human osteosarcoma cells. Cell Physiol. Biochem. 2013, 32 (4), 1083-1096.
30. He, T. C.; Zhou, S.; da Costa, L. T.; Yu, J.; Kinzler, K. W.; Vogelstein, B. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. U.S.A. 1998, 95 (5), 2509-2514.
31. Kang, Q.; Song, W. X.; Luo, Q.; Tang, N.; Luo, J.; Luo, X.; Chen, J.; Bi, Y.; He, B. C.; Park, J. K.; Jiang, W.; Tang, Y.; Huang, J.; Su, Y.; Zhu, G. H.; He, Y.; Yin, H.; Hu, Z.; Wang, Y.; Chen, L.; Zuo, G. W.; Pan, X.; Shen, J.; Vokes, T.; Reid, R. R.; Haydon, R. C.; Luu, H. H.; He, T. C. A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. Stem Cell Dev. 2009, 18 (4), 545-559.
32. Luo, J.; Deng, Z. L.; Luo, X.; Tang, N.; Song, W. X.; Chen, J.; Sharff, K. A.; Luu, H. H.; Haydon, R. C.; Kinzler, K. W.; Vogelstein, B.; He, T. C. A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat. Protoc. 2007, 2 (5), 1236-1247.
33. Peng, Y.; Kang, Q.; Luo, Q.; Jiang, W.; Si, W.; Liu, B. A.; Luu, H. H.; Park, J. K.; Li, X.; Luo, J.; Montag, A. G.; Haydon, R. C.; He, T. C. Inhibitor of DNA binding/differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells. J. Biol. Chem. 2004, 279 (31), 32941-32949.
34. Luo, Q.; Kang, Q.; Si, W.; Jiang, W.; Park, J. K.; Peng, Y.; Li, X.; Luu, H. H.; Luo, J.; Montag, A. G.; Haydon, R. C.; He, T. C. Connective tissue growth factor (CTGF) is regulated by wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells. J. Biol. Chem. 2004, 279 (53), 55958-55968.
35. Huang, J.; Bi, Y.; Zhu, G. H.; He, Y.; Su, Y.; He, B. C.; Wang, Y.; Kang, Q.; Chen, L.; Zuo, G. W.; Luo, Q.; Shi, Q.; Zhang, B. Q.; Huang, A.; Zhou, L.; Feng, T.; Luu, H. H.; Haydon, R. C.; He, T. C.; Tang, N. Retinoic acid signalling induces the differentiation of mouse fetal liver-derived hepatic progenitor cells. Liver Int. 2009, 29 (10), 1569-1581.
36. Zhang, W.; Deng, Z. L.; Chen, L.; Zuo, G. W.; Luo, Q.; Shi, Q.; Zhang, B. Q.; Wagner, E. R.; Rastegar, F.; Kim, S. H.; Jiang, W.; Shen, J.; Huang, E.; Gao, Y.; Gao, J. L.; Zhou, J. Z.; Luo, J.; Huang, J.; Luo, X.; Bi, Y.; Su, Y.; Yang, K.; Liu, H.; Luu, H. H.; Haydon, R. C.; He, T. C.; He, B. C. Retinoic acids potentiate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. PloS One 2010, 5 (7), e11917.
37. Rastegar, F.; Gao, J. L.; Shenaq, D.; Luo, Q.; Shi, Q.; Kim, S. H.; Jiang, W.; Wagner, E. R.; Huang, E.; Gao, Y.; Shen, J.; Yang, K.; He, B. C.; Chen, L.; Zuo, G. W.; Luo, J.; Luo, X.; Bi, Y.; Liu, X.; Li, M.; Hu, N.; Wang, L.; Luther, G.; Luu, H. H.; Haydon, R. C.; He, T. C. Lysophosphatidic acid acyltransferase beta (LPAATbeta) promotes the tumor growth of human osteosarcoma. PloS One 2010, 5 (12), e14182.
38. Su, Y.; Wagner, E. R.; Luo, Q.; Huang, J.; Chen, L.; He, B. C.; Zuo, G. W.; Shi, Q.; Zhang, B. Q.; Zhu, G.; Bi, Y.; Luo, J.; Luo, X.; Kim, S. H.; Shen, J.; Rastegar, F.; Huang, E.; Gao, Y.; Gao, J. L.; Yang, K.; Wietholt, C.; Li, M.; Qin, J.; Haydon, R. C.; He, T. C.; Luu, H. H. Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma. Oncogene 2011, 30 (37), 3907-3917.
39. He, B. C.; Chen, L.; Zuo, G. W.; Zhang, W.; Bi, Y.; Huang, J.; Wang, Y.; Jiang, W.; Luo, Q.; Shi, Q.; Zhang, B. Q.; Liu, B.; Lei, X.; Luo, J.; Luo, X.; Wagner, E. R.; Kim, S. H.; He, C. J.; Hu, Y.; Shen, J.; Zhou, Q.; Rastegar, F.; Deng, Z. L.; Luu, H. H.; He, T. C.; Haydon, R. C. Synergistic antitumor effect of the activated PPARgamma and retinoid receptors on human osteosarcoma. Clin. Cancer Res. 2010, 16 (8), 2235-2245.
40. He, B. C.; Gao, J. L.; Zhang, B. Q.; Luo, Q.; Shi, Q.; Kim, S. H.; Huang, E.; Gao, Y.; Yang, K.; Wagner, E. R.; Wang, L.; Tang, N.; Luo, J.; Liu, X.; Li, M.; Bi, Y.; Shen, J.; Luther, G.; Hu, N.; Zhou, Q.; Luu, H. H.; Haydon, R. C.; Zhao, Y.; He, T. C. Tetrandrine inhibits Wnt/beta-catenin signaling and suppresses tumor growth of human colorectal cancer. Mol. Pharmacol. 2011, 79 (2), 211-219.
41. Huang, E.; Bi, Y.; Jiang, W.; Luo, X.; Yang, K.; Gao, J. L.; Gao, Y.; Luo, Q.; Shi, Q.; Kim, S. H.; Liu, X.; Li, M.; Hu, N.; Liu, H.; Cui, J.; Zhang, W.; Li, R.; Chen, X.; Shen, J.; Kong, Y.; Zhang, J.; Wang, J.; Luo, J.; He, B. C.; Wang, H.; Reid, R. R.; Luu, H. H.; Haydon, R. C.; Yang, L.; He, T. C. Conditionally immortalized mouse embryonic fibroblasts retain proliferative activity without compromising multipotent differentiation potential. PloS One 2012, 7 (2), e32428.
42. Anon, E.; Serra-Picamal, X.; Hersen, P.; Gauthier, N. C.; Sheetz, M. P.; Trepat, X.; Ladoux, B. Cell crawling mediates collective cell migration to close undamaged epithelial gaps. Proc. Natl. Acad. Sci. U.S.A. 2012, 109 (27), 10891-10896.
43. Kam, Y.; Guess, C.; Estrada, L.; Weidow, B.; Quaranta, V. A novel circular invasion assay mimics in vivo invasive behavior of cancer cell lines and distinguishes single-cell motility in vitro. BMC Cancer 2008, 8, 198.
44. He, B. C.; Gao, J. L.; Luo, X.; Luo, J.; Shen, J.; Wang, L.; Zhou, Q.; Wang, Y. T.; Luu, H. H.; Haydon, R. C.; Wang, C. Z.; Du, W.; Yuan, C. S.; He, T. C.; Zhang, B. Q. Ginsenoside Rg3 inhibits colorectal tumor growth through the down-regulation of Wnt/sscatenin signaling. Intl. J. Oncol. 2011, 38 (2), 437-445.
45. Luu, H. H.; Kang, Q.; Park, J. K.; Si, W.; Luo, Q.; Jiang, W.; Yin, H.; Montag, A. G.; Simon, M. A.; Peabody, T. D.; Haydon, R. C.; Rinker-Schaeffer, C. W.; He, T. C. An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis. Clin. Exp. Metastasis 2005, 22 (4), 319-329.
46. Chen, L.; Jiang, W.; Huang, J.; He, B. C.; Zuo, G. W.; Zhang, W.; Luo, Q.; Shi, Q.; Zhang, B. Q.; Wagner, E. R.; Luo, J.; Tang, M.; Wietholt, C.; Luo, X.; Bi, Y.; Su, Y.; Liu, B.; Kim, S. H.; He, C. J.; Hu, Y.; Shen, J.; Rastegar, F.; Huang, E.; Gao, Y.; Gao, J. L.; Zhou, J. Z.; Reid, R. R.; Luu, H. H.; Haydon, R. C.; He, T. C.; Deng, Z. L. Insulin-like growth factor 2 (IGF-2) potentiates BMP- 9-induced osteogenic differentiation and bone formation. J. Bone Miner. Res. 2010, 25 (11), 2447-2459.
47. Luo, J.; Tang, M.; Huang, J.; He, B. C.; Gao, J. L.; Chen, L.; Zuo, G. W.; Zhang, W.; Luo, Q.; Shi, Q.; Zhang, B. Q.; Bi, Y.; Luo, X.; Jiang, W.; Su, Y.; Shen, J.; Kim, S. H.; Huang, E.; Gao, Y.; Zhou, J. Z.; Yang, K.; Luu, H. H.; Pan, X.; Haydon, R. C.; Deng, Z. L.; He, T. C. TGFbeta/BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells. J. Biol. Chem. 2010, 285 (38), 29588-29598.
48. Huang, E.; Zhu, G.; Jiang, W.; Yang, K.; Gao, Y.; Luo, Q.; Gao, J. L.; Kim, S. H.; Liu, X.; Li, M.; Shi, Q.; Hu, N.; Wang, L.; Liu, H.; Cui, J.; Zhang, W.; Li, R.; Chen, X.; Kong, Y. H.; Zhang, J.; Wang, J.; Shen, J.; Bi, Y.; Statz, J.; He, B. C.; Luo, J.; Wang, H.; Xiong, F.; Luu, H. H.; Haydon, R. C.; Yang, L.; He, T. C. Growth hormone synergizes with BMP9 in osteogenic differentiation by activating the JAK/STAT/IGF1 pathway in murine multilineage cells. J. Bone Miner. Res. 2012, 27 (7), 1566-1575.
49. Hu, N.; Jiang, D.; Huang, E.; Liu, X.; Li, R.; Liang, X.; Kim, S. H.; Chen, X.; Gao, J. L.; Zhang, H.; Zhang, W.; Kong, Y. H.; Zhang, J.; Wang, J.; Shui, W.; Luo, X.; Liu, B.; Cui, J.; Rogers, M. R.; Shen, J.; Zhao, C.; Wang, N.; Wu, N.; Luu, H. H.; Haydon, R. C.; He, T. C.; Huang, W. BMP9-regulated angiogenic signaling plays an important role in the osteogenic differentiation of mesenchymal progenitor cells. J. Cell Sci. 2013, 126 (Pt 2), 532-541.
50. Song, J. J.; Celeste, A. J.; Kong, F. M.; Jirtle, R. L.; Rosen, V.; Thies, R. S. Bone morphogenetic protein-9 binds to liver cells and stimulates proliferation. Endocrinology 1995, 136 (10), 4293-4297.
51. Peng, Y.; Kang, Q.; Cheng, H.; Li, X.; Sun, M. H.; Jiang, W.; Luu, H. H.; Park, J. Y.; Haydon, R. C.; He, T. C. Transcriptional characterization of bone morphogenetic proteins (BMPs)-mediated osteogenic signaling. J. Cell Biochem. 2003, 90 (6), 1149-1165.
52. Andersson, E. R.; Sandberg, R.; Lendahl, U. Notch signaling: simplicity in design, versatility in function. Development 2011, 138 (17), 3593-3612.
53. Louvi, A.; Artavanis-Tsakonas, S. Notch and disease: a growing field. Semin. Cell Dev. Biol. 2012, 23 (4), 473-480.
54. Tao, J.; Chen, S.; Lee, B. Alteration of Notch signaling in skeletal development and disease. Ann. N. Y. Acad. Sci. 2010, 1192, 257-268.
55. Bolos, V.; Grego-Bessa, J.; de la Pompa, J. L. Notch signaling in development and cancer. Endocr. Rev. 2007, 28 (3), 339-363.
56. Radtke, F.; Raj, K. The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat. Rev. Cancer 2003, 3 (10), 756-767.